Takeda's sales-op expansion continues

Share this article:

Japanese drugmaker Takeda will launch a new subsidiary in Tel Aviv, the company said today. The announcement marks the sixth “sales entity” the company has opened this year, following Algeria, Peru, Singapore, Ecuador and Vietnam. Takeda Israel Ltd. will supervise sales and marketing for the drugmaker's portfolio in the region. The company couched this as another evolutionary step in its plan to "reinforce growth markets."

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.

Insurers get personal to nip costs

Healthcare insurers seek to curb diabetes costs with interventions that may include house calls.

Novartis dials down RNA research

The drugmaker says the therapeutic approach has a narrow treatment potential.